“Description of the 3 Tranquillo Phase 3 Clinical Program Study Designs to Assess Ritlecitinib Treatment in Adults and Adolescents With Nonsegmental Vitiligo”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s714. Accessed May 25, 2026. https://skin.dermsquared.com/skin/article/view/3860.